In accordance with a settlement agreement with Amgen Inc., STOBOCLO and OSENVELT are expected to be available in the U.S. in June 2025.

THE group of symptoms variously known as effort syndrome, neurocirculatory asthenia, Da Costa's syndrome, soldier's heart and so forth, has occasioned considerable comment in the literature.

"Asthenia" is a medical term used to describe a lack of energy or strength and weakness. While it can affect the entire body, it can be localized to specific body parts or affect mental cognition.

Medically reviewed by Richard N. Fogoros, MD Edarbi (azilsartan) is a high blood pressure medication that may cause side ...